NRP2 and gastric cancer: CAF has been demonstrated to confer 5-fluorouracil (5-FU) resistance to GC cells by expressing neuropilin 2 (NRP2), eventually activating the Hippo pathway and alternatively activating JAK/STAT3 in cancer cells via secreting cytokines.